Joseph M Miller - Net Worth and Insider Trading
Joseph M Miller Net Worth
The estimated net worth of Joseph M Miller is at least $3 Million dollars as of 2024-05-01. Joseph M Miller is the CFO of Aurinia Pharmaceuticals Inc and owns about 495,928 shares of Aurinia Pharmaceuticals Inc (AUPH) stock worth over $3 Million. Joseph M Miller is also the CFO of Avalo Therapeutics Inc and owns about 17 shares of Avalo Therapeutics Inc (AVTX) stock worth over $291. Details can be seen in Joseph M Miller's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Joseph M Miller has not made any transactions after 2024-03-06 and currently still holds the listed stock(s).
Transaction Summary of Joseph M Miller
Joseph M Miller Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joseph M Miller owns 2 companies in total, including Avalo Therapeutics Inc (AVTX) , and Aurinia Pharmaceuticals Inc (AUPH) .
Click here to see the complete history of Joseph M Miller’s form 4 insider trades.
Insider Ownership Summary of Joseph M Miller
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVTX | Avalo Therapeutics Inc | 2021-12-31 | director |
| AUPH | Aurinia Pharmaceuticals Inc | 2024-03-06 | Chief Financial Officer |
Joseph M Miller Latest Holdings Summary
Joseph M Miller currently owns a total of 2 stocks. Among these stocks, Joseph M Miller owns 495,928 shares of Aurinia Pharmaceuticals Inc (AUPH) as of March 6, 2024, with a value of $3 Million and a weighting of 99.99%. Joseph M Miller also owns 17 shares of Avalo Therapeutics Inc (AVTX) as of December 10, 2019, with a value of $291 and a weighting of 0.01%.
Latest Holdings of Joseph M Miller
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc | 2024-03-06 | 495,928 | 5.09 | 2,524,274 |
| AVTX | Avalo Therapeutics Inc | 2019-12-10 | 17 | 17.12 | 291 |
Holding Weightings of Joseph M Miller
Joseph M Miller Form 4 Trading Tracker
According to the SEC Form 4 filings, Joseph M Miller has made a total of 5 transactions in Aurinia Pharmaceuticals Inc (AUPH) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in Aurinia Pharmaceuticals Inc is the sale of 34,811 shares on March 6, 2024, which brought Joseph M Miller around $194,942.
According to the SEC Form 4 filings, Joseph M Miller has made a total of 2 transactions in Avalo Therapeutics Inc (AVTX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Avalo Therapeutics Inc is the acquisition of 1 shares on December 10, 2019, which cost Joseph M Miller around $7,404.
Insider Trading History of Joseph M Miller
- 1
Joseph M Miller Trading Performance
GuruFocus tracks the stock performance after each of Joseph M Miller's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joseph M Miller is -8.66%. GuruFocus also compares Joseph M Miller's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joseph M Miller within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Joseph M Miller's insider trading performs compared to the benchmark.
Performance of Joseph M Miller
Average Return
-29.96%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 17.11 | -8.66 | 34.75 | -29.96 | -15.78 | -53.22 |
| Relative Return to S&P 500(%) | 13.7 | -9.4 | 27.31 | -37.4 | -30.28 | -62.44 |
Joseph M Miller Ownership Network
Ownership Network List of Joseph M Miller
Ownership Network Relation of Joseph M Miller
Joseph M Miller Owned Company Details
What does Avalo Therapeutics Inc do?
Who are the key executives at Avalo Therapeutics Inc?
Joseph M Miller is the director of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include director & 10 percent owner Armistice Capital Master Fund Ltd. , 10 percent owner Caissa Capital Management Ltd. , and Interim CFO Christopher Ryan Sullivan .
Avalo Therapeutics Inc (AVTX) Insider Trades Summary
Over the past 18 months, Joseph M Miller made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net purchase of 206,169 shares made by Caissa Capital Management Ltd. , a net sale of 3,233,542 shares made by Armistice Capital Master Fund Ltd. , and a net purchase of 6,083 shares made by Garry Arthur Neil .
In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc (AVTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,348 shares of Avalo Therapeutics Inc (AVTX) were sold and 2,762 shares were bought by its insiders, resulting in a net sale of 12,587 shares.
Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avalo Therapeutics Inc Insider Transactions
Joseph M Miller Mailing Address
Above is the net worth, insider trading, and ownership report for Joseph M Miller. You might contact Joseph M Miller via mailing address: C/o Cerecor Inc., 400 East Pratt Street, Suite 606, Baltimore Md 21202.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
